Ryvu Therapeutics S.A.

WSE:RVU Stock Report

Market Cap: zł1.2b

Ryvu Therapeutics Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Pawel Przewiezlikowski

Chief executive officer

zł341.4k

Total compensation

CEO salary percentage48.2%
CEO tenureno data
CEO ownership17.6%
Management average tenure2.6yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

Despite Lacking Profits Ryvu Therapeutics (WSE:RVU) Seems To Be On Top Of Its Debt

Oct 20
Despite Lacking Profits Ryvu Therapeutics (WSE:RVU) Seems To Be On Top Of Its Debt

We're Keeping An Eye On Ryvu Therapeutics' (WSE:RVU) Cash Burn Rate

Aug 02
We're Keeping An Eye On Ryvu Therapeutics' (WSE:RVU) Cash Burn Rate

Are Investors Undervaluing Ryvu Therapeutics S.A. (WSE:RVU) By 20%?

Jan 25
Are Investors Undervaluing Ryvu Therapeutics S.A. (WSE:RVU) By 20%?

What Type Of Shareholders Own The Most Number of Ryvu Therapeutics S.A. (WSE:RVU) Shares?

Feb 05
What Type Of Shareholders Own The Most Number of Ryvu Therapeutics S.A. (WSE:RVU) Shares?

Shareholders Of Ryvu Therapeutics (WSE:RVU) Must Be Happy With Their 261% Total Return

Dec 14
Shareholders Of Ryvu Therapeutics (WSE:RVU) Must Be Happy With Their 261% Total Return

CEO Compensation Analysis

How has Pawel Przewiezlikowski's remuneration changed compared to Ryvu Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-zł94m

Dec 31 2023n/an/a

-zł92m

Sep 30 2023n/an/a

-zł73m

Jun 30 2023n/an/a

-zł66m

Mar 31 2023n/an/a

-zł75m

Dec 31 2022zł341kzł165k

-zł84m

Sep 30 2022n/an/a

-zł94m

Jun 30 2022n/an/a

-zł105m

Mar 31 2022n/an/a

-zł92m

Dec 31 2021zł1mn/a

-zł79m

Sep 30 2021n/an/a

-zł72m

Jun 30 2021n/an/a

-zł61m

Mar 31 2021n/an/a

-zł41m

Dec 31 2020n/an/a

-zł32m

Sep 30 2020n/an/a

-zł40m

Jun 30 2020n/an/a

-zł32m

Mar 31 2020n/an/a

-zł41m

Dec 31 2019zł524kzł524k

-zł44m

Sep 30 2019n/an/a

-zł53m

Jun 30 2019n/an/a

-zł60m

Mar 31 2019n/an/a

-zł28m

Dec 31 2018zł476kzł476k

-zł23m

Sep 30 2018n/an/a

zł2m

Jun 30 2018n/an/a

zł14m

Mar 31 2018n/an/a

zł21m

Dec 31 2017zł655kzł655k

zł6m

Compensation vs Market: Pawel's total compensation ($USD86.66K) is below average for companies of similar size in the Polish market ($USD310.24K).

Compensation vs Earnings: Pawel's compensation has been consistent with company performance over the past year.

CEO

Pawel Przewiezlikowski

no data

Tenure

zł341,388

Compensation

Mr. Pawel Tadeusz Przewiezlikowski, MSc., MBA, serves as the Chief Executive Officer of BioCentrum Sp. z o.o. Mr. Przewiezlikowski serves as a Member of Supervisory Board of SELVITA S.A.Mr. Przewiezlikow...

Leadership Team

NamePositionTenureCompensationOwnership
Pawel Przewiezlikowski
Founderno datazł341.39k17.58%
PLN 218.3m
Krzysztof Brzózka
Executive VP12.3yrszł595.51k1.16%
PLN 14.4m
Kamil Sitarz
COO & Member of the Management Board3.5yrszł485.54k0.17%
PLN 2.1m
Vatnak Vat-Ho
Chief Business Officer & Member of Management Board1.8yrszł937.98k0.12%
PLN 1.5m
Hendrik Nogai
Chief Medical Officer & Member of Management Board1.8yrszł728.01k0.058%
PLN 724.9k
Paulina Wolanin
Human Resources Managerno datano datano data

2.6yrs

Average Tenure

Experienced Management: RVU's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Smith
Member of Supervisory Boardless than a yearno datano data
Rafal Chwast
Independent Member of the Supervisory Boardno datazł150.48k0.52%
PLN 6.5m
Tadeusz Wesolowski
Non-Independent Vice Chairman of Supervisory Boardno datazł148.26k0.40%
PLN 5.0m
Scott Fields
Member of Supervisory Boardless than a yearno datano data
Piotr Romanowski
Independent Chairman of the Supervisory Board13.3yrszł150.48k0.22%
PLN 2.7m
Axel Glasmacher
Non-Independent Member of the Supervisory Board4.7yrszł148.26kno data
Thomas Turalski
Non-Independent Member of the Supervisory Board4.7yrszł148.26k0.087%
PLN 1.1m

4.7yrs

Average Tenure

63yo

Average Age

Experienced Board: RVU's board of directors are considered experienced (4.7 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.